ANI PHARMACEUTICALS, INC (ANIP) Shares outstanding analysis
- Shares outstanding · latest quarter: Value 22.96M; Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
- Shares outstanding · 1 year ago: Value (m); Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
- Shares outstanding · 5 years ago: Value (m); Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
- Shares change · vs previous quarter: Value (m); Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
Shares outstanding analysis
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Shares outstanding · latest quarter | 22.96M | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. |
| Shares outstanding · 1 year ago | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. |
| Shares outstanding · 5 years ago | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. |
| Shares change · vs previous quarter | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. Calculation unavailable: missing inputs remain (m). |
| Shares count change · vs previous quarter | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current quarter shares | 22.96M shares | |
| Previous quarter shares | (m) |
Shares means common shares outstanding, adjusted to the same split basis for comparison. It is a count, not USD or convertible securities; B means billion shares.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current quarter shares (shares) | Shares count change · vs previous quarter | Shares change (%) · vs previous quarter |
|---|---|---|---|
| 2026-06-30 | 22.96M | (m) | (m) |
| 2026-03-31 | 22.73M | (m) | (m) |
| 2025-09-30 | 22.46M | (m) | (m) |
| 2025-06-30 | 21.69M | (m) | (m) |
| 2025-03-31 | 21.65M | (m) | (m) |
| 2024-12-31 | 21.76M | (m) | (m) |
| 2024-09-30 | 21.02M | (m) | (m) |
| 2024-06-30 | 21.03M | (m) | (m) |
| 2024-03-31 | 20.96M | (m) | (m) |
| 2023-12-31 | 21.07M | (m) | (m) |
| 2023-09-30 | 20.43M | (m) | (m) |
| 2023-06-30 | 20.28M | (m) | (m) |
| 2023-03-31 | 17.96M | (m) | (m) |
| 2022-12-31 | 17.49M | (m) | (m) |
| 2022-09-30 | 17.45M | (m) | (m) |
| 2022-06-30 | 17.43M | (m) | (m) |
| 2022-03-31 | 17.24M | (m) | (m) |
| 2021-12-31 | 17.26M | (m) | (m) |
| 2021-09-30 | 12.74M | (m) | (m) |
| 2021-06-30 | 12.75M | (m) | (m) |
| 2021-03-31 | 12.73M | (m) | (m) |
| 2020-12-31 | 12.35M | (m) | (m) |
| 2020-09-30 | 12.35M | (m) | (m) |
| 2020-06-30 | 12.30M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |